Wound Management News

Granuloma annulare is more common among women and middle-aged individuals, but it remains a rare disease in the United States.

The FDA has expanded its approval of the Recell system in combination with meshed autografting to include treatment of acute full-thickness thermal burn wounds in pediatric patients, Avita Medical announced in a press release.

Timolol may be an effective and inexpensive treatment for wound healing, according to a poster presented at AAD VMX 2021.

Traumatic skin wounds may be a risk factor for infective endocarditis in the weeks after wound development, according to findings published in Heart.

Researchers will analyze the safety and efficacy of gene-corrected fibroblasts for the treatment of recessive dystrophic epidermolysis bullosa, according to a presentation at the South Beach Symposium Medical Dermatology Summit.

The first patient has been dosed in a phase 3 clinical trial of debcoemagene autoficel for the treatment of recessive dystrophic epidermolysis bullosa, Castle Creek Biosciences announced in a press release.

A novel wound dressing system optimized topical drug absorption in pediatric patients after ablative fractional laser treatment, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Forehead flaps, as well as other two-stage reconstructions for nasal defects, can be replaced by single-stage reconstructions most of the time, according to a presentation at the American Society for Dermatologic Surgery annual meeting.

Stratatech has completed rolling submission of a biologics license application to the FDA for StrataGraft, according to a press release.

MAUI, HAWAII — Clinicians should avoid prescribing opioids when treating venous leg ulcers, a speaker at Maui Derm said.